Federated Hermes’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Federated Hermes’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100	Closed	-$1K	–	2315
2022 Q3	$1K	Buy	+100	New	+$567	﹤0.01%	2116
2021 Q4	–	Sell	-441	Closed	-$2K	–	2348
2021 Q3	$2K	Sell	441 -621	-58%	-$3.29K	﹤0.01%	2114
2021 Q2	$7K	Buy	1,062 +705	+197%	+$3.8K	﹤0.01%	2015
2021 Q1	$2K	Sell	357 -197	-36%	-$1.19K	﹤0.01%	2143
2020 Q4	$3K	Buy	+554	New	+$2.39K	﹤0.01%	2110

Other funds holding STSA

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Federated Hermes's STSA Position: Q4 2022 in Review

Federated Hermes sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q4 2022, closing a stake of 100 shares — an estimated $1K sold.

Federated Hermes first reported a position in STSA in Q4 2020 and held it in 5 quarters. The position peaked at $7K in Q2 2021. 33 funds tracked by Wall St. Rank hold STSA as of Q4 2022.

Federated Hermes reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Federated Hermes sold 100 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $1K.
Federated Hermes first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Federated Hermes's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $7K in Q2 2021.
33 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.